LivingGLP1
crossover randomized trial

NCT02049034

The Effect of Lixisenatide on Postprandial Lipid and Glucose Metabolism in Patients with Type 2 Diabetes

Design

Randomized
Start year
2014
Treatment
4 weeks, follow-up 12 weeks
Countries
United Kingdom (1 sites)
Sponsor
University of Surrey (industry)
Eligibility
white men 40 to 65; type 2 diabetes on metformin monotherapy; HbA1c 7.5 to 9.5 percent

Conduct and analysis

Blinding
double blind
Sequence generation
computer
Allocation concealment
pharmacy or sealed
Outcome adjudication
not reported
Primary estimand
not stated
Analysis population
Missing data

Arms

ArmTreatmentBackgroundRandomizedAnalyzedCompleted treatment
A1Lixisenatide 20 ug subcutaneous once daily
Lixisenatide
metformin; lifestyle: not reported8
A2Placebo
Placebo
metformin; lifestyle: not reported8

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.
CharacteristicStatisticLixisenatide 20 ug subcutaneous once daily
A1
Placebo
A2
Whole trial
ALL
agemean (years)57.3
agese (years)1.9
bmimean (kg/m2)30.3
bmise (kg/m2)1.0
hba1cmean (percent)8.2
hba1cse (percent)0.3
other malen8
weightmean (kg)91.892.2
weightse (kg)3.42.9

Results

12 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
HbA1c change (2 lines; O01)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
4A1final7.2 percent0.3not stated; other; R0018624:Table 1
4A2final7.9 percent0.3not stated; other; R0018624:Table 1
Body weight change in kilograms (diabetes) (2 lines; O02)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
4A1final89.4 kg3.3not stated; other; R0018624:Table 1
4A2final90.7 kg3.1not stated; other; R0018624:Table 1
All cause mortality (2 lines; O20)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 8not stated; other; R0018624:Results
A2events0 / 8not stated; other; R0018624:Results
Hospitalization for heart failure (2 lines; O23)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 8not stated; other; R0018624:Results
A2events0 / 8not stated; other; R0018624:Results
Serious adverse events (2 lines; O25)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 8not stated; other; R0018624:Results
A2events0 / 8not stated; other; R0018624:Results
Death by suicide (2 lines; O35B)
WeekArmStatisticEstimateSE or SD95% CIEvents / NDetail
A1events0 / 8not stated; other; R0018624:Results
A2events0 / 8not stated; other; R0018624:Results